Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

13 trials with published results (13%)

Research Maturity

58 completed trials (57% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.9%

7 terminated out of 101 trials

Success Rate

89.2%

+2.7% vs benchmark

Late-Stage Pipeline

15%

15 trials in Phase 3/4

Results Transparency

22%

13 of 58 completed with results

Key Signals

13 with results89% success

Data Visualizations

Phase Distribution

76Total
Not Applicable (25)
Early P 1 (1)
P 1 (10)
P 2 (25)
P 3 (10)
P 4 (5)

Trial Status

Completed58
Unknown15
Terminated7
Recruiting7
Active Not Recruiting7
Not Yet Recruiting3

Trial Success Rate

89.2%

Benchmark: 86.5%

Based on 58 completed trials

Clinical Trials (101)

Showing 20 of 20 trials
NCT05797246Phase 2Active Not RecruitingPrimary

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

NCT00471250Recruiting

Collection of Lung Fluid and Tissue Samples for Research

NCT07552779Phase 1Recruiting

A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir

NCT06004440Active Not Recruiting

Real World Registry for Use of the Ion Endoluminal System

NCT05907564Not ApplicableActive Not Recruiting

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

NCT06494241Active Not Recruiting

Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study

NCT06376084Active Not Recruiting

Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC

NCT01264055Completed

Cross-sectional Characterization of Idiopathic Bronchiectasis

NCT06841874Unknown

Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC

NCT04657120Not ApplicableCompleted

Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy

NCT07122661Active Not Recruiting

STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)

NCT06691971Recruiting

AeviceMD for Detection of Wheeze in Pediatric and Adult Populations

NCT06647654Active Not Recruiting

Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy

NCT07196917Not Yet Recruiting

Prospective Cohort of Integrated Traditional Chinese and Western Medicine in China

NCT06149494Phase 2Completed

RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection

NCT04170348Phase 2Completed

Daily Vitamin D for Sickle-cell Respiratory Complications

NCT05056766Completed

How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolved According to Propulsion: Control With Each mm of Advancement

NCT03843541Phase 3CompletedPrimary

A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions

NCT04263038Phase 4Recruiting

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

NCT06988943Not ApplicableRecruiting

Early Intervention Strategies for Lung Cancer

Scroll to load more

Research Network

Activity Timeline